Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rallybio (RLYB) Current Assets (2023 - 2025)

Rallybio (RLYB) has disclosed Current Assets for 3 consecutive years, with $61.3 million as the latest value for Q4 2025.

  • Quarterly Current Assets fell 9.71% to $61.3 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $61.3 million through Dec 2025, down 9.71% year-over-year, with the annual reading at $61.3 million for FY2025, 9.71% down from the prior year.
  • Current Assets hit $61.3 million in Q4 2025 for Rallybio, down from $66.6 million in the prior quarter.
  • In the past five years, Current Assets ranged from a high of $161.3 million in Q1 2023 to a low of $50.3 million in Q2 2025.
  • Historically, Current Assets has averaged $93.9 million across 3 years, with a median of $84.8 million in 2024.
  • Biggest YoY gain for Current Assets was 9.71% in 2025; the steepest drop was 45.03% in 2025.
  • Year by year, Current Assets stood at $114.8 million in 2023, then crashed by 40.9% to $67.8 million in 2024, then dropped by 9.71% to $61.3 million in 2025.
  • Business Quant data shows Current Assets for RLYB at $61.3 million in Q4 2025, $66.6 million in Q3 2025, and $50.3 million in Q2 2025.